Literature DB >> 618441

Treatment of patients with pseudomonas endocarditis with high dose aminoglycoside and carbenicillin therapy.

M P Reyes, W J Brown, A M Lerner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 618441     DOI: 10.1097/00005792-197801000-00004

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


× No keyword cloud information.
  12 in total

1.  [S2 Guideline for diagnosis and therapy of infectious endocarditis].

Authors:  C K Naber
Journal:  Z Kardiol       Date:  2004-12

2.  Gram-negative endocarditis.

Authors:  Milagros P Reyes; Katherine C Reyes
Journal:  Curr Infect Dis Rep       Date:  2008-07       Impact factor: 3.725

Review 3.  Value of the serum bactericidal test in management of patients with bacterial endocarditis.

Authors:  J W Mellors; D L Coleman; V T Andriole
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

4.  Efficacy of ciprofloxacin in experimental aortic valve endocarditis caused by a multiply beta-lactam-resistant variant of Pseudomonas aeruginosa stably derepressed for beta-lactamase production.

Authors:  A S Bayer; P Lindsay; J Yih; L Hirano; D Lee; I K Blomquist
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

5.  Efficacy of amikacin and ceftazidime in experimental aortic valve endocarditis due to Pseudomonas aeruginosa.

Authors:  A S Bayer; D Norman; K S Kim
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

6.  Efficacy of ceftazidime and aztreonam alone or in combination with amikacin in experimental left-sided Pseudomonas aeruginosa endocarditis.

Authors:  A Pefanis; H Giamarellou; P Karayiannakos; I Donta
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

7.  Comparative efficacies of ciprofloxacin and pefloxacin alone or in combination with fosfomycin in experimental endocarditis induced by multidrug-susceptible and -resistant Pseudomonas aeruginosa.

Authors:  Y Q Xiong; G Potel; J Caillon; G Stephant; F Jehl; D Bugnon; P Le Conte; D Baron; H Drugeon
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

8.  Pharmacokinetics of tobramycin and gentamicin in abusers of intravenous drugs.

Authors:  C H King; R J Creger; J J Ellner
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

9.  Gentamicin dosing strategies for dogs with subclinical renal dysfunction.

Authors:  D L Frazier; J E Riviere
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

10.  Addition of rifampin to carboxypenicillin-aminoglycoside combination for the treatment of Pseudomonas aeruginosa infection: clinical experience with four patients.

Authors:  V L Yu; J J Zuravleff; J E Peacock; D DeHertogh; L Tashjian
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.